Preclinical evaluation of GW406108X, a broad-spectrum therapeutic blocking ULK1/2-mediated autophagy to inhibit enterovirus replication.
- DOI
- 10.1016/j.apsb.2026.06.052
- Published
- 2026 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.06.052,
title = {Preclinical evaluation of GW406108X, a broad-spectrum therapeutic blocking ULK1/2-mediated autophagy to inhibit enterovirus replication.},
author = {Fong YD and Yogarajah T and Khoo XW and Chan YS and Mohameed JBH and Neo A and Yi B and Chu JJH},
year = {2026},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2026.06.052},
url = {https://doi.org/10.1016/j.apsb.2026.06.052}
}RIS
TY - JOUR TI - Preclinical evaluation of GW406108X, a broad-spectrum therapeutic blocking ULK1/2-mediated autophagy to inhibit enterovirus replication. AU - Fong YD AU - Yogarajah T AU - Khoo XW AU - Chan YS AU - Mohameed JBH AU - Neo A AU - Yi B AU - Chu JJH PY - 2026 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2026.06.052 UR - https://doi.org/10.1016/j.apsb.2026.06.052 ER -
APA
YD, F., T, Y., XW, K., YS, C., JBH, M., A, N., B, Y., & JJH, C. (2026). Preclinical evaluation of GW406108X, a broad-spectrum therapeutic blocking ULK1/2-mediated autophagy to inhibit enterovirus replication.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.06.052
Source records
- pubmed · retrieved 2026-09-25T03:21:40.508Z